GB2463566B - Formulations active against propionibacteria - Google Patents

Formulations active against propionibacteria

Info

Publication number
GB2463566B
GB2463566B GB0916030A GB0916030A GB2463566B GB 2463566 B GB2463566 B GB 2463566B GB 0916030 A GB0916030 A GB 0916030A GB 0916030 A GB0916030 A GB 0916030A GB 2463566 B GB2463566 B GB 2463566B
Authority
GB
United Kingdom
Prior art keywords
active against
formulations active
against propionibacteria
propionibacteria
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0916030A
Other versions
GB2463566A (en
GB0916030D0 (en
Inventor
Scott Seville
Stephen Philip Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntopix Group PLC
Original Assignee
Syntopix Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntopix Group PLC filed Critical Syntopix Group PLC
Publication of GB0916030D0 publication Critical patent/GB0916030D0/en
Publication of GB2463566A publication Critical patent/GB2463566A/en
Application granted granted Critical
Publication of GB2463566B publication Critical patent/GB2463566B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
GB0916030A 2008-09-16 2009-09-14 Formulations active against propionibacteria Expired - Fee Related GB2463566B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0816878.3A GB0816878D0 (en) 2008-09-16 2008-09-16 Formulations

Publications (3)

Publication Number Publication Date
GB0916030D0 GB0916030D0 (en) 2009-10-28
GB2463566A GB2463566A (en) 2010-03-24
GB2463566B true GB2463566B (en) 2010-11-24

Family

ID=39930196

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0816878.3A Ceased GB0816878D0 (en) 2008-09-16 2008-09-16 Formulations
GB0916030A Expired - Fee Related GB2463566B (en) 2008-09-16 2009-09-14 Formulations active against propionibacteria

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0816878.3A Ceased GB0816878D0 (en) 2008-09-16 2008-09-16 Formulations

Country Status (2)

Country Link
GB (2) GB0816878D0 (en)
WO (1) WO2010032041A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112657D0 (en) * 2011-07-22 2011-09-07 Lowe Nicholas J Compositions for treatment of skin disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133964A (en) * 1994-11-05 1996-05-28 Nichiban Co Ltd Injurious ultraviolet light-absorbing adhesive sheet
US20040086575A1 (en) * 2002-11-04 2004-05-06 Smith Jeffrey B. Anti-viral compositions and methods of making and using the anti-viral compositions
GB2447747A (en) * 2007-03-17 2008-09-24 Syntopix Ltd Antibacterial formulations comprising bisphenol compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140627A (en) * 1974-04-25 1975-11-11
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
GB2456376A (en) * 2008-12-22 2009-07-15 Syntopix Ltd Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133964A (en) * 1994-11-05 1996-05-28 Nichiban Co Ltd Injurious ultraviolet light-absorbing adhesive sheet
US20040086575A1 (en) * 2002-11-04 2004-05-06 Smith Jeffrey B. Anti-viral compositions and methods of making and using the anti-viral compositions
GB2447747A (en) * 2007-03-17 2008-09-24 Syntopix Ltd Antibacterial formulations comprising bisphenol compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WPI Abstract Accession No 1996-306465/31 & JP 8133964A *

Also Published As

Publication number Publication date
WO2010032041A3 (en) 2010-09-10
GB0816878D0 (en) 2008-10-22
GB2463566A (en) 2010-03-24
GB0916030D0 (en) 2009-10-28
WO2010032041A2 (en) 2010-03-25

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GEP20135845B (en) Orally-disintegrating solid formulation
GB2459691B (en) Formulations
HUE031343T2 (en) Immunity-inducing agent
GB0823269D0 (en) Formulations
GB0718435D0 (en) Wpund care formulation
EP2296713A4 (en) Disinfecting formulation
ZA201102446B (en) Oral formulation
GB0821789D0 (en) Formulations
EP2307021A4 (en) Formulations
GB0822633D0 (en) Formulation
IL206577A0 (en) Formulations of flibanserin
IL199771A0 (en) Active substance combination
GB0800788D0 (en) Niovel formulation
EP2294049A4 (en) Orally active curcuminoid compounds
HK1156209A1 (en) Stable benzimidazole formulation
GB0814376D0 (en) Formulation
GB2463566B (en) Formulations active against propionibacteria
ZA201202168B (en) Formulations comprising triptan compounds
AP2612A (en) Improved herbicidal formulation
GB0921378D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
PL384798A1 (en) Insecticidal agent
PL384436A1 (en) Active vibroinsulator
GB0918912D0 (en) Improved medicament formulation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130914